PRAXIS PRECISION MEDICINES I
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small-molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The Company’s product candidates include ulixacaltamide, vormatrigine, relutrigine, PRAX-080, and others.
Find out what a historical investment in PRAXIS PRECISION MEDICINES I would be worth today using our PRAX stock calculator.
$4.75B
-
0.00%
15.21K
$199.53
$180.93
$0.00
$206.71
$26.70
Ready to start your investing journey with Stake?
Open an accountPRAX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRAX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRAX
on Stake
Buy PRAX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRAX from only US$10 with fractional shares
